MedTrace Logo

Establishment of a Early Risk Model of ECMO in Children With ARDS

NCT04710173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2024-02-07

No results posted yet for this study

Summary

The key problem in the treatment of ARDS is refractory hypoxemia. Extracorporeal Membrane Oxygenation (ECMO) is an extracorporeal oxygenation of venous blood to eliminate carbon dioxide and return to the body. It has been an important part of the rescue treatment for ARDS. This study intends to explore the timing of ECMO. The main research hypothesis is that the appropriate timing of ECMO treatment can improve the weaning success rate and survival rate of children with severe ARDS; it is expected to provide a basis for determining the best timing of ECMO treatment

Conditions

  • ARDS

Interventions

PROCEDURE

ECMO

VV-ECMO

Sponsors & Collaborators

  • The Children's Hospital of Zhejiang University School of Medicine

    collaborator OTHER

  • Children's Hospital of Chongqing Medical University

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Ye Cheng, doctor · Children's Hospital of Fudan University

Eligibility

Min Age
28 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710173 on ClinicalTrials.gov